4026
D. Catel et al. / Tetrahedron 68 (2012) 4018e4028
242.153. Anal. Calcd for C16H19NO (241.34): C, 79.63; H, 7.94; N,
5.80. Found: C, 79.89; H, 7.99; N, 5.68.
4.2.1.12. 2,2-Dimethyl-1-(pyridin-2-yl)-1-(phenyl)-1-propanol
(2l). 2-Bromopyridine (100 L, 1.05 mmol, 1 equiv), 2,2-
dimethylpropiophenone (263 L, 1.6 mmol, 1.5 equiv), trapping
m
m
4.2.1.7. (4-Nitrophenyl)(pyridin-2-yl)methanol (2g).29 2-Bromo-
pyridine (100 mL, 1.05 mmol, 1 equiv), p-nitrobenzaldehyde
(237 mg, 1.6 mmol, 1.5 equiv) as a THF solution (2 mL), trapping
step reaction time: t¼1 h. Yield: 75% (180 mg). Yellow powder,
mp¼109e112 ꢁC. Rf¼0.22 (cyclohexane/ethyl acetate: 5:5). 1H NMR
step reaction time: t¼21 h. Yield: 60% (150 mg). White powder,
mp¼81e82 ꢁC. Rf¼0.20 (pentane/diethyl ether: 1:0.1). 1H NMR
(250 MHz, CDCl3):
d
8.51 (d, JHH¼4.8 Hz, 1H), 7.84e7.64 (m, 4H),
7.34e7.14 (m, 4H), 6.42 (br, 1H), 1.07 (s, 9H). 13C NMR (62.5 MHz,
CDCl3):
d 162.5, 146.9, 144.3, 136.2, 128.3, 127.3, 126.6, 123.0, 122.2,
(250 MHz, CDCl3):
d
8.59 (d, JHH¼4.8 Hz, 1H), 8.19 (d, JHH¼8.5 Hz,
81.4, 39.9, 27.1. HRMS calcd for C16H20NO [MþH]þ: 242.154. Found:
242.154. Anal. Calcd for C16H19NO (241.33): C, 79.63; H, 7.94; N,
5.80. Found: C, 79.64; H, 8.07; N, 5.54.
2H), 7.67 (td, JHH¼7.8, 1.8 Hz, 1H), 7.59 (d, JHH¼8.5 Hz, 2H),
7.30e7.21 (m,1H), 7.16 (d, JHH¼8.0 Hz,1H), 5.85 (s,1H), 5.37 (br,1H).
13C NMR (62.5 MHz, CDCl3):
d 159.4, 150.5, 148.4, 147.6, 137.4, 127.8,
123.9, 123.2, 121.3, 74.3. HRMS calcd for C12H10N2NaO3 [MþNa]þ:
253.058. Found: 253.059. Anal. Calcd for C12H10N2O3 (230.22): C,
62.60; H, 4.38; N, 12.17. Found: C, 62.65; H, 4.45; N, 12.16.
4.2.1.13. (4-Methoxyphenyl)-(3-methoxypyridin-2-yl)methanol
(5). 2-Bromo-3-methoxypyridine (197 mg, 1.05 mmol, 1 equiv) as
a THF solution (2 mL), p-anisaldehyde (191 mL, 1.6 mmol, 1.5 equiv),
trapping step reaction time: t¼1.5 h. Yield: 51% (130 mg). White
powder, mp¼124e127 ꢁC. Two purifications by silica gel column
chromatography were performed using first cyclohexane/ethyl
acetate (6:4) as eluent (Rf¼0.28) and then cyclohexane/ethyl ace-
4.2.1.8. (Pyridin-2-yl)(4-(trifluoromethyl)phenyl)methanol (2h).4,30
2-Bromopyridine (100
benzaldehyde (215
mL, 1.05 mmol, 1 equiv), p-(trifluoromethyl)
m
L, 1.6 mmol, 1.5 equiv), trapping step reaction
time: t¼1 h. Yield: 83% (220 mg). White powder, mp¼66e68 ꢁC.
tate (2:8) (Rf¼0.61). 1H NMR (250 MHz, CDCl3):
d 8.17 (d,
Rf¼0.29 (cyclohexane/ethyl acetate: 5:5). 19F NMR (235 MHz, CDCl3):
JHH¼4.5 Hz, 1H), 7.28 (d, JHH¼8.5 Hz, 2H), 7.23e7.15 (m, 1H),
7.14e7.07 (m, 1H), 6.81 (d, JHH¼8.5 Hz, 2H), 5.90 (s, 1H), 5.41 (br,
d
ꢀ62.5 (s). 1H NMR (250 MHz, CDCl3):
8.58 (d, JHH¼4.8 Hz, 1H), 7.65
d
(d, JHH¼7.8, 1.8 Hz, 1H), 7.60 (d, JHH¼8.2 Hz, 2H), 7.52 (d, JHH¼8.2 Hz,
2H), 7.27e7.19 (m, 1H), 7.14 (d, JHH¼8.0 Hz, 1H), 5.80 (s, 1H), 5.34 (br,
1H), 3.75 (s, 3H), 3.74 (s, 3H). 13C NMR (62.5 MHz, CDCl3):
d 158.9,
152.3, 150.7, 139.4, 135.6, 128.3, 123.3, 117.9, 113.6, 70.0, 55.4, 55.3.
HRMS calcd for C14H16NO3 [MþH]þ: 246.112. Found: 246.112. Anal.
Calcd for C14H15NO3 (245.27): C, 68.56; H, 6.16; N, 5.71. Found: C,
68.77; H, 6.22; N, 5.66.
1H). 13C NMR (62.5 MHz, CDCl3):
d 160.0, 148.1, 147.1, 137.1, 130.0 (q,
2JCF¼32 Hz), 127.3, 125.5 (q, 3JCF¼3.8 Hz), 124.1 (q, 1JCF¼272 Hz), 122.8,
121.3, 74.4. HRMS calcd for C13H11F3NO [MþH]þ: 254.079. Found:
254.079. Anal. Calcd for C13H10F3NO (253.22): C, 61.66; H, 3.98; N,
5.53. Found: C, 61.65; H, 4.06; N, 5.36.
4.2.1.14. (4-Methoxyphenyl)-(6-methoxypyridin-2-yl)methanol
(6). 2-Bromo-6-methoxypyridine (129
a THF solution (2 mL), p-anisaldehyde (191
m
L, 1.05 mmol, 1 equiv) as
4.2.1.9. (Pyridin-2-yl)(o-tolyl)methanol (2i).23 2-Bromopyridine
mL, 1.6 mmol, 1.5 equiv),
(100
m
L, 1.05 mmol, 1 equiv), o-tolualdehyde (182
m
L, 1.6 mmol,
trapping step reaction time: t¼2 h. Yield: 89% (230 mg). Orange oil.
1.5 equiv), trapping step reaction time: t¼1 h. Yield: 81% (170 mg).
Rf¼0.12 (cyclohexane/dichloromethane: 1:9). 1H NMR (250 MHz,
White powder, mp¼59e60 ꢁC. Rf¼0.25 (cyclohexane/ethyl acetate:
CDCl3):
d 7.56e7.44 (m, 1H), 7.35e7.24 (m, 2H), 6.93e6.81 (m, 2H),
7:3). 1H NMR (250 MHz, CDCl3):
d
8.58 (d, JHH¼4.5 Hz, 1H), 7.59 (td,
6.71e6.57 (m, 2H), 5.63 (d, JHH¼4.2 Hz, 1H), 4.90 (d, JHH¼4.2 Hz,
JHH¼7.8, 1.5 Hz, 1H), 7.27e7.12 (m, 5H), 7.02 (d, JHH¼7.8 Hz,1H), 5.96
1H), 3.99 (s, 3H), 3.79 (s, 3H). 13C NMR (62.5 MHz, CDCl3):
d
163.3,
(s,1H), 5.18 (br,1H), 2.33 (s, 3H). 13C NMR (62.5 MHz, CDCl3):
d
161.1,
159.3, 159.2, 139.6, 135.6, 128.4, 114.0, 113.8, 109.2, 74.4, 55.4, 53.6.
HRMS calcd for C14H15NNaO3 [MþNa]þ: 268.094. Found: 268.095.
Anal. Calcd for C14H15NO3 (245.27): C, 68.56; H, 6.16; N, 5.71. Found:
C, 68.67; H, 6.19; N, 5.62.
147.9, 140.8, 136.9, 136.4, 131.0, 128.2, 128.0, 126.3, 122.4, 121.3, 73.0,
19.6. HRMS calcd for C13H13NNaO [MþNa]þ: 222.089. Found:
222.089. Anal. Calcd for C13H13NO (199.25): C, 78.36; H, 6.58; N,
7.03. Found: C, 78.70; H, 6.63; N, 6.73.
4.2.1.15. (4-Methoxyphenyl)(quinolin-2-yl)methanol
Bromoquinoline (218 mg, 1.05 mmol, 1 equiv) as a THF solution
(2 mL), p-anisaldehyde (191 L, 1.6 mmol, 1.5 equiv), trapping step
(7).33 2-
4.2.1.10. (1-Naphthyl)(pyridin-2-yl)methanol
pyridine (100 L, 1.05 mmol, 1 equiv), 1-naphthaldehyde (213
(2j).31 2-Bromo-
L,
m
m
m
1.6 mmol, 1.5 equiv), trapping step reaction time: t¼1 h. Yield: 85%
reaction time: t¼1.5 h. Yield: 56% (160 mg). Yellow oil. Two puri-
fications by silica gel column chromatography were performed
using first cyclohexane/ethyl acetate (7:3) as eluent (Rf¼0.36) and
then cyclohexane/ethyl acetate (8:2) (Rf¼0.17). 1H NMR (250 MHz,
(200 mg). White powder, mp¼75e77 ꢁC. Rf¼0.33 (cyclohexane/
ethyl acetate: 5:4). 1H NMR (250 MHz, CDCl3):
d
8.59 (d, JHH¼4.0 Hz,
1H), 8.15e8.05 (m, 1H), 7.88e7.75 (m, 2H), 7.54e7.36 (m, 5H),
7.20e7.10 (m, 1H), 7.02 (d, JHH¼7.8 Hz,1H), 6.41 (s, 1H), 5.25 (br, 1H).
CDCl3):
d
8.14 (d, JHH¼8.5 Hz, 1H), 8.05 (d, JHH¼8.5 Hz, 1H),
13C NMR (62.5 MHz, CDCl3):
d
161.1, 147.9, 138.2, 137.0, 134.3, 131.3,
7.84e7.71 (m, 2H), 7.59e7.51 (m, 1H), 7.31 (d, JHH¼8.5 Hz, 2H), 7.16
(d, JHH¼8.5 Hz, 1H), 6.87 (d, JHH¼8.5 Hz, 2H), 6.00 (br, 1H), 5.83 (s,
128.9, 128.8, 126.2, 125.7, 125.4, 124.5, 122.5,121.5, 73.6. HRMS calcd
for C16H13NNaO [MþNa]þ: 258.089. Found: 258.090. Anal. Calcd for
C16H13NO (235.28): C, 81.68; H, 5.57; N, 5.95. Found: C, 81.70; H,
5.19; N, 5.73.
1H), 3.78 (s, 3H). 13C NMR (62.5 MHz, CDCl3):
d 160.9, 159.6, 146.1,
137.1, 135.2, 130.1, 129.0, 128.9, 127.7, 126.7, 119.5, 114.2, 74.8, 55.4.
HRMS calcd for C17H16NO2 [MþH]þ: 266.118. Found: 266.118. Anal.
Calcd for C17H15NO2 (265.31): C, 76.96; H, 5.70; N, 5.28. Found: C,
76.72; H, 5.91; N, 5.04.
4.2.1.11. 2,2-Dimethyl-1-(pyridin-2-yl)-1-propanol (2k).32 2-Bro-
mopyridine (100
(171
mL, 1.05 mmol, 1 equiv), trimethylacetaldehyde
m
L, 1.6 mmol, 1.5 equiv), trapping step reaction time: t¼2 h.
4.2.2. Procedure for BreMg exchange of 3- and 4-bromopyridine
involving racemic (BINOLate)Bu2MgLi2. In a Schlenk tube, flushed
under argon, rac-BINOL (0.3 g, 1.05 mmol, 1 equiv) was dissolved in
anhydrous THF (7.5 mL). n-BuLi (1.5 M in hexanes, 1.4 mL,
2.1 mmol, 2 equiv) was slowly added at ꢀ5 ꢁC. After stirring at this
temperature for 1 h, n-BuMgCl (2.1 M in THF, 0.50 mL, 1.05 mmol,
1 equiv) was added at ꢀ5 ꢁC and the resulting solution was stirred
for additional 1 h at the same temperature. n-BuLi (1.5 M in hex-
anes, 0.7 mL, 1.05 mmol, 1 equiv) was added at ꢀ5 ꢁC and the
Yield: 58% (100 mg). Orange solid, mp¼51e54 ꢁC. Rf¼0.25 (cyclo-
hexane/ethyl acetate: 7:3). 1H NMR (250 MHz, CDCl3):
d 8.55
(d, JHH¼4.0 Hz, 1H), 7.63 (td, JHH¼7.5, 1.5 Hz, 1H), 7.23e7.14 (m, 2H),
4.34 (s, 2H), 0.92 (s, 9H). 13C NMR (62.5 MHz, CDCl3):
d
160.0,
148.0, 135.6, 123.0, 122.4, 80.4, 36.4, 26.0. HRMS calcd for
C10H16NO [MþH]þ: 166.123. Found: 166.122. Anal. Calcd for
C10H15NO (165.23): C, 72.69; H, 9.15; N, 8.48. Found: C, 72.73; H,
8.94; N, 8.34.